Clinical, genetic, and epidemiological support services task order
Active Awarded Last action
- Contract number
- 75N91023F00004
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,881,002
Award facts
- Contract value 42% obligated
-
- $14,223,989.00 Current, with exercised options
- $21,248,975.00 Potential, with all options
- Completion date 53% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $687,200 | |
| Funding Only Action | $725,000 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,090,980 | |
| Change Order | $0 | |
| Exercise an Option | $2,237,993 | |
| Funding Only Action | $1,144,830 | |
| Funding Only Action | $200,000 | |
| Funding Only Action | $250,000 | |
| Funding Only Action | $500,000 | |
| Original award | $1,045,000 |
Show all 11
About this award
The National Cancer Institute issued a delivery order to Westat, Inc. on September 1, 2023, with a ceiling value of $21.2 million for clinical, genetic, and epidemiological support services under the Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services parent IDIQ. The order is priced on a cost-plus-fixed-fee basis and runs through August 31, 2029.
Place of performance is Rockville, MD. The order funds field operations and biospecimen collection support for the National Cancer Institute's cancer epidemiology research portfolio. Westat self-performs all labor; SCI reporting shows FY2025 activity of 10.1 FTEs with no subcontractors. FY2024 invoicing was $3.1 million (derived rate $107.41/hr across 28,552 contractor hours), and FY2025 invoiced $2.7 million. Labor footprint has moderated year-over-year, reflecting variable staffing demands across the order's research cycles.
Quick answers
Who was awarded contract 75N91023F00004?
75N91023F00004 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2023.
How much is contract 75N91023F00004 worth?
The government has obligated $8,881,002 on 75N91023F00004. Its current value, with exercised options, is $14,223,989. Its potential value, with all options, is $21,248,975.
Is contract 75N91023F00004 an order under another contract?
Yes. 75N91023F00004 is a delivery order under 75N91022D00006, an indefinite delivery contract, on Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services.
Was contract 75N91023F00004 competed?
The extent of competition for 75N91023F00004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award